Intellia (NTLA) is a publicly traded Healthcare sector company. As of July 5, 2026, NTLA trades at $17.56 with a market cap of $2.45B and a P/E ratio of -4.61. NTLA moved +1.86% today. Year to date, NTLA is +93.82%; over the trailing twelve months it is +63.65%. Its 52-week range spans $5.90 to $28.25. Analyst consensus is buy with an average price target of $21.06. Rallies surfaces NTLA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for NTLA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $17.56 |
| Market Cap | $2.45B |
| P/E Ratio | -4.61 |
| EPS | $-3.81 |
| Dividend Yield | 0.00% |
| 52-Week High | $28.25 |
| 52-Week Low | $5.90 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $67.67M |
| Net Income | $-412.69M |
| Gross Margin | 0.00% |
18 analysts cover NTLA: 0 strong buy, 8 buy, 8 hold, 2 sell, 0 strong sell. Consensus rating is buy. Average price target: $21.06.